Persistence of bone and mineral disorders 2 years after successful kidney transplantation

Transplantation

Volumn 96, Issue 3, 2013, Pages 290-296

  Neves, Carolina L ^a   Dos Reis, Luciene M ^a   Batista, Daniella G ^a   Custodio, Melani R ^a   Graciolli, Fabiana G ^a   Martin, Rita De Cassia T ^a   Neves, Katia R ^a   Dominguez, Wagner V ^a   Moyses, Rosa M ^a   Jorgetti, Vanda ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bone histomorphometry; Kidney transplantation; Mineral metabolism; Osteoblast

Indexed keywords

ALKALINE PHOSPHATASE; CORTICOSTEROID;

ADULT; ARTICLE; BONE BIOPSY; BONE DISEASE; BONE MASS; BONE MINERALIZATION; BONE TURNOVER; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCALCEMIA; HYPOPHOSPHATEMIA; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MALE; MINERAL DEFICIENCY; MORPHOMETRICS; OSTEOBLAST; OSTEOID; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURFACE PROPERTY; TRABECULAR BONE; VITAMIN D DEFICIENCY;

ADULT; ALKALINE PHOSPHATASE; BONE DISEASES; CALCIFICATION, PHYSIOLOGIC; FEMALE; HUMANS; HYPERCALCEMIA; HYPOPHOSPHATEMIA; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARATHYROID HORMONE; POSTOPERATIVE COMPLICATIONS; VITAMIN D;

EID: 84881612925     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182985468     Document Type: Article

References (39)

1. Julian BA, Laskow DA, Dubovsky J, et al. Rapid loss of vertebral mineral density after renal transplantation. NEngl J Med 1991; 325: 544.
2. Falkiewicz K, Boratynska M, Zmonarski SC, et al. Evolution of bone disease at 2 years after transplantation: a single-center study. Transplant Proc 2009; 41: 3063.
3. Bradenburg VM, Pollitt D, Ketteler M, et al. Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation. Transplantation 2004; 77: 1566.
4. Patel S, Kwan JTC, Mccloskey E, et al. Prevalence and cause of low bone density and fractures in kidney transplant patients. J Bone Miner Res 2001; 16: 1863.
5. Durieux S, Mercadal L, Orcel P, et al. Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation 2002; 74: 496.
6. Rojas E, Carlini RG, Clesca P, et al. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int 2003; 63: 1915.
7. Westeel FP, Mazouz H, Ezaitouni F, et al. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation. Kidney Int 2000; 58: 1788.
8. Marcén R, Caballero C, Pascual J, et al. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study. Transplantation 2006; 81: 826.
9. Borchhardt K, Sulzbacher I, Benesch T, et al. Low-turnover bone disease in hypercalcemic hyperparathyroidism after kidney transplantation. Am J Transplant 2007; 7: 2515.
10. Lehman G, Ott U, Stein G, et al. Renal osteodystrophy after successful renal transplantation: a histomorphometric analysis in 57 patients. Transplant Proc 2007; 39: 3153.
11. Cruz EA, Lugon JR, Jorgetti V, et al. Histologic evolution of bone disease 6 months after successful kidney transplantation. Am J Kidney Dis 2004; 44: 747.
12. Rolla D, Ballanti P, Marsano L, et al. Bone disease in long-term renal transplant recipients with severe osteopenia: a cross-sectional study. Transplantation 2006; 81: 915.
13. Cueto-Manzano AM, Konel S, Crowley V, et al. Bone histopathology and densitometry comparison between cyclosporine A monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients. Transplantation 2003; 75: 2053.
14. Montalban C, Francisco ALM, Marinoso ML, et al. Bone disease in long-term adult kidney transplant patients with normal renal function. Kidney Int 2003; 63: S129.
15. Parker CR, Blackwell PJ, Freemont A, et al. Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women. Am J Kidney Dis 2002; 40: 385.
16. Monier-Faugere MC, Mawad H, QI Q, et al. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 2000; 11: 1093.
17. Carlini RG, Rojas E, Weisinger JR, et al. Bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis 2000; 36: 160.
18. Shaker JL, Lukert BP. Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am 2005; 34: 341.
19. Velasquez-Forero F, Mondragon A, Herrero B, et al. Adynamic bone lesion in renal transplant recipients with normal renal function. Nephrol Dial transplant 1996; 11: 58.
20. Evenepoel P, Claes K, Kuypers D, et al. Natural History of parathyroid function and calcium metabolism after kidney transplantation: a single-center study. Nephrol Dial Transplant 2004; 19: 1281.
21. Giannini S, Stella S, Silva-Netto F, et al. Persistent secondary hyperparathyroidism and vertebral fractures in kidney transplantation: role of calcium-sensing receptor polymorphisms and vitamin D deficiency. J Bone Miner Res 2010; 25: 841.
22. Evenepoel P, Meijers BK, de Jonge H, et al. Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation. Clin J Am Soc Nephrol 2008; 3: 1829.
23. Bhan I, Shah A, Holmes J, et al. Post-transplant hypophosphatemia: tertiary "hyper-phosphatoninism" Kidney Int 2006; 70: 1486.
24. Bayrakci US, Baskin E, Ozcay F, et al. Renal Fanconi syndrome and myopathy after liver transplantation: drug-related mitochondrial cytopathy Pediatr Transplant 2008; 12: 109.
25. Tripathi SS, Gibney EM, Gehr TWB, et al. High prevalence of vitamin D deficiency in African American kidney transplant recipients. Transplantation 2008; 85: 767.
26. Holick MF, Vitamin D. Importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004; 79: 362.
27. Stavroulopoulos A, Cassidy MJ, Porter CJ, et al. Vitamin D status in renal transplantation recipients. Am J Transplant 2007; 7: 2546.
28. Luo L, Shi Y, Bai Y, et al. Impact of tacrolimus on bone metabolism after kidney transplantation. Int Immunopharmacol 2012; 13: 69.
29. Fukunaga J, Yamaai T, Yamachika E, et al. Expression of osteoclast differentiation factor and osteoclastogenesis inhibitory factor in rat osteoporosis induced by immunosuppressant FK506. Bone 2004; 34: 425.
30. Hirotani H, Tuohy NA,Woo JT, et al. The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 2004; 279: 13984.
31. Varanasi SS, Datta HK. Characterisation of cytosolic FK506 binding protein 120 and its role in modulating expression of Cbfa1 and Osterix in ROS 17/2.8 cells. Bone 2005; 36: 243.
32. Sun L, Blair HC, Peng Y, et al. Calcineurin regulates bone formation by the osteoblast. Proc Natl Acad Sci USA 2005; 102: 17130.
33. Benaboud S, Urien S, Thervet E, et al. Determination of optimal cholecalciferol treatment in renal transplant recipients using a population pharmacokinetic approach. Eur J Clin Pharmacol 2013; 69: 499.
34. Methodology of mineralized bone histology. In: Malluche HH, Faugere MC, eds. Atlas of mineralized bone histology. Basel, Switzerland: Karger; 1986: 17Y24.
35. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. J Bone Miner Res 1987; 2: 595.
36. Dos Reis LM, Batalha JR, Munoz DR, et al. Brazilian normal static bone histomorphometry: effects of age, sex, and race. J Bone Miner Metab 2007; 25: 400.
37. Rehman MT, Hoyland JA, Denton J, et al. Age related histomorphometric changes in bone in normal British men and women. J Clin Pathol 1994; 47: 529.
38. Moe S, Drüeke T, Cunningham J, et al. Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2006; 69: 1945.
39. Dias CB, dos Reis LM, Caparbo VF, et al. Decreased in vitro osteoblast proliferation and low turnover bone disease in nonuremic proteinuric patients. Kidney Int 2007; 71: 562.